๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A gene-alteration profile of human lung cancer cell lines

โœ Scribed by Raquel Blanco; Reika Iwakawa; Moying Tang; Takashi Kohno; Barbara Angulo; Ruben Pio; Luis M. Montuenga; John D. Minna; Jun Yokota; Montse Sanchez-Cespedes


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
314 KB
Volume
30
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Aberrant proteins encoded from genes altered in tumors drive cancer development and may also be therapeutic targets. Here we derived a comprehensive gene-alteration profile of lung cancer cell lines. We tested 17 genes in a panel of 88 lung cancer cell lines and found the rates of alteration to be higher than previously thought. Nearly all cells feature inactivation at TP53 and CDKN2A or RB1, whereas BRAF, MET, ERBB2, and NRAS alterations were infrequent. A preferential accumulation of alterations among histopathological types and a mutually exclusive occurrence of alterations of CDKN2A and RB1 as well as of KRAS, epidermal growth factor receptor (EGFR), NRAS, and ERBB2 were seen. Moreover, in nonsmall-cell lung cancer (NSCLC), concomitant activation of signal transduction pathways known to converge in mammalian target of rapamycin (mTOR) was common. Cells with single activation of ERBB2, PTEN, or MET signaling showed greater sensitivity to cell-growth inhibition induced by erlotinib, LY294002, and PHA665752, respectively, than did cells featuring simultaneous activation of these pathways, underlining the need for combined therapeutic strategies in targeted cancer treatments. In conclusion, our gene-alteration landscape of lung cancer cell lines provides insights into how gene alterations accumulate and biological pathways interact in cancer.


๐Ÿ“œ SIMILAR VOLUMES


Expression of cytokeratin 19 mRNA in hum
โœ Yutaka Ueda; Jiro Fujita; Shuji Bandoh; Satoko Hojo; Yasufumi Yamaji; Yuji Ohtsu ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 111 KB ๐Ÿ‘ 2 views

The present study was designed to clarify the mechanism by which some lung cancer cell lines can produce cytokeratin 19 (CK19) fragment and others cannot. We hypothesized that some lung cancer cell lines which cannot release CK19 express an incomplete sequence of CK19 mRNA. Expression of mRNA was ev

Regulation of DNA repair gene expression
โœ Claire J. McGurk; Michele Cummings; Beate Kรถberle; John A. Hartley; R. Timothy O ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 349 KB ๐Ÿ‘ 1 views

## Abstract Although most advanced cancers are incurable, the majority of testicular germ cell tumors can be cured using cisplatinโ€based combination chemotherapy. The nucleotide excision repair (NER) pathway removes most DNA adducts produced by cisplatin, and the low levels of NER in testis tumor c

Expression profile of eukaryotic transla
โœ Pius Joseph; Christina M. O'Kernick; Sreekumar Othumpangat; Yi-Xiong Lei; Bao-Zh ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 173 KB

## Abstract Several studies have demonstrated the overexpression of certain eukaryotic translation factors in human cancer cell lines and in malignant tissues. In this study, with human cancer cell lines derived from lungs, breast, prostate, and skin, we have examined the expression profile of 36 t

Steroid-hormone receptors in cell lines
โœ Ulrich Kaiser; Jรผrgen Hofmann; Margret Schilli; Bรคrbel Wegmann; Uwe Klotz; Steff ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 745 KB

Female gender is a significant independent favorable prognostic factor in lung cancer. To study the possible role of sex hormones in lung cancer, the expression of sex-steroid receptors and the glucocorticoid receptor was investigated in 29 lung-cancer cell lines stemming from small-cell lung cancer

Altered protein-expressing profile in hP
โœ Lan-Tu Gou; Ai-Ping Tong; Fei Yan; Zhu Yuan; Fei He; Wei Wang; Yan Zhou; Li-Juan ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 371 KB

## Abstract Human __PNAS4__ (h__PNAS4__) is a recently identified proโ€apoptosis gene, which is able to induce apoptosis in A549 human lung adenocarcinoma cells following its overexpression. In this work, we investigated the changes of protein profile in h__PNAS4__โ€induced apoptosis in A549 cells th